Analysis of intracellular modifications
AssigneeDiscoveRx Corporation
InventorsJoseph Horecka, Peter Fung, Richard M. Eglen
Life of this patent
Estimating the term…
Loading patent…
AssigneeDiscoveRx Corporation
InventorsJoseph Horecka, Peter Fung, Richard M. Eglen
Estimating the term…
Improved methods of determining the intracellular state of a protein as well as modifications of the protein are provided by introducing a surrogate fusion protein comprising a member of an enzyme fragment complementation complex and a target protein. After exposing cells transformed with the surrogate fusion protein to a change in environment, e.g. a candidate drug, the cells are lysed, the lysate separated into fractions or bands, conveniently by gel electrophoresis and transferring the proteins by Western blot to a membrane. The bands on the membrane are developed using the other member of the enzyme fragment complementation complex and a substrate providing a detectable signal. The method is found to provide high sensitivity and the ability to observe modifications of the target protein.
A method for performing a Western blot for determining modification of an intracellular target protein in a transfected cell using a fusion protein serving as a surrogate protein for said-target protein, said surrogate protein comprising an enzyme donor (ED), wherein said ED is a member of an enzyme fragment complementation pair of β-galactosidase that forms an active enzyme with the complementary enzyme acceptor fragment (EA) and said surrogate protein is modified in said cell in the same manner as said target protein, said modification occurring as a result of changes in the environment of said cell where said modifications result in a change in the migration rate of said surrogate protein in gel electrophoresis, wherein said method comprises:
Dependencies are inferred from the claim text.